Allosteric Tuning of Caspase‐7: A Fragment‐Based Drug Discovery Approach
Abstract: The caspase family of cysteine proteases are highly sought‐after drug targets owing to their essential roles in apoptosis, proliferation, and inflammation pathways. High‐throughput screening efforts to discover inhibitors have gained little traction. Fragment‐based screening has emerged as a powerful approach for the discovery of innovative drug leads. This method has become a central facet of drug discovery campaigns in the pharmaceutical industry and academia. A fragment‐based drug discovery campaign against human caspase‐7 resulted in the discovery of a novel series of allosteric inhibitors. An X‐ray crystal structure of caspase‐7 bound to a fragment hit and a thorough kinetic characterization of a zymogenic form of the enzyme were used to investigate the allosteric mechanism of inhibition. This work further advances our understanding of the mechanisms of allosteric control of this class of pharmaceutically relevant enzymes, and provides a new path forward for drug discovery efforts.
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Allosteric Tuning of Caspase‐7: A Fragment‐Based Drug Discovery Approach ; volume:129 ; number:46 ; year:2017 ; pages:14635-14639 ; extent:5
Angewandte Chemie ; 129, Heft 46 (2017), 14635-14639 (gesamt 5)
- Urheber
-
Vance, Nicholas R.
Gakhar, Lokesh
Spies, M. Ashley
- DOI
-
10.1002/ange.201706959
- URN
-
urn:nbn:de:101:1-2022091607411166822850
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:35 MESZ
Datenpartner
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Vance, Nicholas R.
- Gakhar, Lokesh
- Spies, M. Ashley
Ähnliche Objekte (12)
Allosteric Tuning of Caspase‐7: A Fragment‐Based Drug Discovery Approach
Allosteric Tuning of Caspase‐7: Establishing the Nexus of Structure and Catalytic Power
Fragment-based approaches in drug discovery
Fragment-based drug discovery : lessons and outlook
Fragment-based drug discovery and X-ray crystallography
Proteome‐Wide Fragment‐Based Ligand and Target Discovery
Identification of Allosteric Inhibitors against Active Caspase-6
Targeting Trypanosoma brucei FPPS by Fragment-based drug discovery
Fragment-based discovery of BACE1 inhibitors using functional assays
Discovery and Characterization of Allosteric Antibodies
Cotranscriptional folding and fragment-based drug discovery of regulatory mRNA
Targeting farnesyl pyrophosphate synthase of Trypanosoma cruzi by fragment-based lead discovery
Allosteric Tuning of Caspase‐7: A Fragment‐Based Drug Discovery Approach
Allosteric Tuning of Caspase‐7: Establishing the Nexus of Structure and Catalytic Power
Fragment-based approaches in drug discovery
Fragment-based drug discovery : lessons and outlook
Fragment-based drug discovery and X-ray crystallography
Proteome‐Wide Fragment‐Based Ligand and Target Discovery
Identification of Allosteric Inhibitors against Active Caspase-6
Targeting Trypanosoma brucei FPPS by Fragment-based drug discovery
Fragment-based discovery of BACE1 inhibitors using functional assays
Discovery and Characterization of Allosteric Antibodies
Cotranscriptional folding and fragment-based drug discovery of regulatory mRNA
Targeting farnesyl pyrophosphate synthase of Trypanosoma cruzi by fragment-based lead discovery
Allosteric Tuning of Caspase‐7: A Fragment‐Based Drug Discovery Approach
Allosteric Tuning of Caspase‐7: Establishing the Nexus of Structure and Catalytic Power
Fragment-based approaches in drug discovery
Fragment-based drug discovery : lessons and outlook
Fragment-based drug discovery and X-ray crystallography
Proteome‐Wide Fragment‐Based Ligand and Target Discovery
Identification of Allosteric Inhibitors against Active Caspase-6
Targeting Trypanosoma brucei FPPS by Fragment-based drug discovery
Fragment-based discovery of BACE1 inhibitors using functional assays
Discovery and Characterization of Allosteric Antibodies
Cotranscriptional folding and fragment-based drug discovery of regulatory mRNA